BROWN MICHAEL S sold REGN
October 30, 2026 · Form 4 insider transaction
BROWN MICHAEL S sold 1,929 shares of Regeneron Pharmaceuticals, Inc. at $875.00 per share, a transaction worth $1.69M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,929
Price
$875.00
Total value
$1.69M
InsiderBROWN MICHAEL S
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 30, 2026
Filing dateNovember 3, 2026
Shares owned after1,380
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 25, 2026.